<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: 505(b)(2) Drug Approvals Rock</title>
	<atom:link href="http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/</link>
	<description>Freshly Brewed Bio/Pharma Chat. Served Up Daily.</description>
	<lastBuildDate>Wed, 10 Mar 2010 16:00:30 -0500</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Sakuntala</title>
		<link>http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/comment-page-1/#comment-53139</link>
		<dc:creator>Sakuntala</dc:creator>
		<pubDate>Tue, 03 Jun 2008 11:33:43 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/#comment-53139</guid>
		<description>Can a generic player file both ANDA or 505(b)(2) application for the same drug product. How 30 months stay is effected, if we challenge the same patent for both ANDA and 505(b)(2) applications, . Will a generic player is subjected to multiple 30 months stay or single 30 month stay?</description>
		<content:encoded><![CDATA[<p>Can a generic player file both ANDA or 505(b)(2) application for the same drug product. How 30 months stay is effected, if we challenge the same patent for both ANDA and 505(b)(2) applications, . Will a generic player is subjected to multiple 30 months stay or single 30 month stay?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Cornelius Diamond</title>
		<link>http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/comment-page-1/#comment-49119</link>
		<dc:creator>Cornelius Diamond</dc:creator>
		<pubDate>Wed, 23 Apr 2008 17:27:14 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/#comment-49119</guid>
		<description>Does 505 b offer a path for biogenerics as well?</description>
		<content:encoded><![CDATA[<p>Does 505 b offer a path for biogenerics as well?</p>
]]></content:encoded>
	</item>
</channel>
</rss>
